المؤلفون: M. Agaltsov V., O. Drapkina M., K. Davtyan V., G. Arutyunyan G., М. Агальцов В., О. Драпкина М., К. Давтян В., Г. Арутюнян Г.

المصدر: Rational Pharmacotherapy in Cardiology; Vol 15, No 1 (2019); 36-42 ; Рациональная Фармакотерапия в Кардиологии; Vol 15, No 1 (2019); 36-42 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2019-15-1

مصطلحات موضوعية: atrial fibrillation, obstructive sleep apnea, surgical treatment of atrial fibrillation, hypertension, obesity, cardiorespiratory sleep monitoring, фибрилляция предсердий, обструктивное апноэ сна, хирургическое лечение фибрилляции предсердий, артериальная гипертензия, ожирение, кардиореспираторное мониторирование сна

وصف الملف: application/pdf

Relation: https://www.rpcardio.com/jour/article/view/1855/1768; Wolf P.A., Benjamin E.J., Belanger A.J., et al. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J. 1996;131:790-5. doi:10.1016/S0002-8703(96)90288-4.; Chugh S., Havmoeller R., Narayanan K, et al. Worldwide Epidemiology of Atrial Fibrillation. A Global Burden of Disease 2010 Study. Circulation. 2014;129:837-47. doi:10.1161/CIRCULATIONAHA.113.005119.; Krijthe B.P., Kunst A., Benjamin E.J.,https://www.ncbi.nlm.nih.gov/pubmed/?term=Heeringa%20J%5BAuthor%5D&cauthor=true&cauthor_uid=23900699 et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746-51. doi:10.1093/eurheartj/eht280.; Piccini J.P., Hammill B.G., Sinner M.F., et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes. 2012;5:85- 93. doi:10.1161/CIRCOUTCOMES.111.962688.; Stewart S., Hart C.L., Hole D.J., et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359-64. doi:10.1016/S0002-9343(02)01236-6.; Soliman E.Z., Safford M.M., Muntner P., et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174:107-14. doi:10.1001/jamainternmed.2013.11912.; Gami A.S., Hodge D.O., Herqes R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. Journal of the American College of Cardiology. 2007;49(5):565-571. doi:10.1016/j.jacc.2006.08.060.; Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-962. doi:10.1016/j.rec.2016.11.033.; Chen L.Y., Shen W.K. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm. 2007;4:S1-S6. doi:10.1016/j.hrthm.2006.12.018.; Cappato R., Calkins H., Chen S.A., et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111(9):1100-5. doi:10.1161/CIRCEP.109.859116.; Ernst S., Ouyang F., Löber F., et al. Catheter-induced linear lesions in the left atrium in patients with atrial fibrillation: an electroanatomic study. Journal of the American College of Cardiology. 2003; 42(7):1271-82. doi:10.1016/S0735-1097(03)00940-9.; Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-962. doi:10.1093/eurheartj/ehw210.; Parati G., Lombardi C., Hedner J., et al. EU COST Action B26 members Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J. 2013;41:523-38. doi:10.1183/09031936.00226711.; Epstein L.J., Kristo D., Strollo P.J., et al. Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med, 2009;5:263-76.; Szymanski F.M., Filipiak K.J., Platek A.E., et al. Assessment of CHADS2 and CHA2DS2-VASc scores in obstructive sleep apnea patients with atrial fibrillation. Sleep Breath. 2015;19(2):531-7. doi:10.1007/s11325-014-1042-5.; Yaranov D.M., Smyrlis A., Usatii N., et al. Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation. Am J Cardiol. 2015;115(4):461-5. doi:10.1016/j.amjcard. 2014.11.027.; Gami A.S., Pressman G., Caples S.M., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004; 110:364-7. doi:10.1161/01.Cir.0000136587.68725.8e.; Ng C.Y., Liu T., Shehata M., et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108(1):47-51. doi:10.1016/j.amjcard.2011.02.343.; Linz D., McEvoy R.D., Cowie M.R., et al. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: A Review. JAMA Cardiol. 2018;3(6):532-40. doi:10.1001/jamacardio.2018.0095.; Senaratna C.V., Perret J.L., Lodge C.J., et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Medicine Reviews. 2017;34:70-81. doi:10.1016/j.smrv.2016.07.002.; Narkiewicz K., Somers V.K. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand. 2003;177:385-90. doi:10.1046/j.1365-201X.2003.01091.x.; Somers V.K., Zavala D.C., Mark A.L., et al. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol. 1989;67:2095-100. doi:10.1152/jappl.1989.67.5.2095.; Drager L.F., Bortolotto L.A., Pedrosa R.P., et al. Left atrial diameter is independently associated with arterial stiffness in patients with obstructive sleep apnea: potential implications for atrial fibrillation. Int J Cardiol. 2010;144:257-59. doi:10.1016/j.ijcard.2009.01.018.; Hoffmann M.S., Singh P., Wolk R., et al. Obstructive sleep apnea and intermittent hypoxia increase expression of dual specificity phosphatase 1. Atherosclerosis. 2013;231:378-83. doi:10.1016/j.atherosclerosis.2013.09.033.; Kanagala R., Murali N.S., Friedman P.A., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589-94. doi:10.1161/01.CIR.0000068337.25994.21.; Szymanski F., Filipiak K., Platek A. et al. Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study. Sleep Breath. 2015;19:849-56. doi:10.1007/s11325-014-1102-x.; Hoit B.D. Left atrial size and function. Role in prognosis. J Am Coll Cardiol. 2014;63:493-505. doi:10.1016/j.jacc.2013.10.055.; Tops L.F., Delgado V., Bertini M., et al. Left atrial strain predicts reverse remodeling after catheter ablation for atrial fibrillation J Am Coll Cardiol. 2011;57:324-31. doi:10.1016/j.jacc.2013.10.055.; Hammerstingl C., Schwekendiek M., Momcilovic D., et al. Left atrial deformation imaging with ultrasound based two-dimensional speckle-tracking predicts the rate of recurrence of paroxysmal and persistent atrial fibrillation after successful ablation procedures J Cardiovasc Electrophysiol. 2012;23:247-55. doi:10.1111/j.1540-8167.2011.02177.x.; Osranek M., Bursi F., Bailey K.R., et al. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J. 2006;26:2556- 61. doi:10.1093/eurheartj/ehi483.; Jongnarangsin K., Chugh A., Good E. et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:668-72. doi:10.1111/j.1540-8167.2008.01118.x.; Hoyer F.F., Lickfett L.M., Mittmann-Braun E., et al. High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation. J Interv Card Electrophysiol. 2010;29(1):37-41. doi:10.1007/s10840-010-9502-8.; Stevenson I.H., Teichtahl H., Cunnington D., et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J. 2008;29(13):1662-9. doi:10.1093/eurheartj/ehn214.; https://www.rpcardio.com/jour/article/view/1855

الاتاحة: https://www.rpcardio.com/jour/article/view/1855
https://doi.org/10.20996/1819-6446-2019-15-1-36-42

المؤلفون: A. Tarasov V., K. Davtyan V., S. Martsevich Yu., А. Тарасов В., К. Давтян В., С. Марцевич Ю.

المصدر: Rational Pharmacotherapy in Cardiology; Vol 13, No 1 (2017); 18-24 ; Рациональная Фармакотерапия в Кардиологии; Vol 13, No 1 (2017); 18-24 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2017-13-1

مصطلحات موضوعية: atrial fibrillation, radiofrequency ablation of pulmonary veins, the early postoperative period, verapamil, propafenone, sotalol, PROOF study, фибрилляция предсердий, радиочастотная аблация устья легочных вен, ранний послеоперационный период, верапамил, пропафенон, соталол, исследование ПРУФ

وصف الملف: application/pdf

Relation: https://www.rpcardio.com/jour/article/view/1408/1427; Kirchhof P., Benussi S., Kotecha D., et al. 2016 Esc Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the ESC. Developed with the special contribution of the EHRA of the ESC. Endorsed by the ESO. Eur Heart J. 2016;37(38):2893-962.; January C.T., Wann S., Alpert J.S., et al. 2014 AHA/ACC/HRS Guidelines for the Management of Pa- tients With Atrial Fibrillation: Executive Summary. J Am Coll Cardiol. 2014;64(21):e1-76.; Diagnostics and management of atrial fibrillation. RSC and RNSA guidelines, 2012. Rossiyskiy Kardi- ologicheskiy Zhurnal. 2013;4(102) suppl 3:6-76. (In Russ.) [Диагностика и лечение фибрилляции предсердий. Рекомендации РКО и ВНОА, 2012. Российский Кардиологический Журнал. 2013; 4(102) приложение 3: 6-76].; Schotten U., Verheule S., Kirchhof P., Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91(1):265-325.; Pappone E., Rosanio S., Oreto G., et al. Circumferential Radiofrequency Ablation of Pulmonary Vein Os- tia A New Anatomic Approach for Curing Atrial Fibrillation Carlo. Circulation. 2000;102:2619-28.; Julio J., Chierchia G.B., Chierchia C., et al. Regular atrial tachycardias following vein isolation for parox- ysmal atrial fibrillation: a comparison between the cryoballoon and radiofrequency techniques. J In- terv Card Electrophysiol. 2015;42:161-9.; Calkins H., Brugada J., Packer D.L., et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm. 2007;4(6): 816-61.; Calkins H., Kuck K.H., Cappato R., et al. 2012 HRS/EHRA/ECAS Expert Consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528-606.; Tarasov A.V., Davtyan K.V., Martsevich S.Yu., Shatakhtsyan V.S. Prevention of atrial tachyarrhythmia in post-operation period of pulmonary veins ostia catheter isolation in paroxysmal atrial fibrillation. Kar- diovaskulyarnaya Terapiya i Profilaktika. 2016;15(5):43-9. (In Russ.) [Тарасов А.В., Давтян К.В., Мар- цевич С.Ю., Шатахцян В.С. Профилактика предсердных тахиаритмий в послеоперационном пе- риоде катетерной изоляции устьев легочных вен у пациентов с пароксизмальной формой фиб- рилляции предсердий. Кардиоваскулярная Терапия и Профилактика. 2016;15(5):43-9].; Sokolov S.F. Allapinin and modern approaches to the treatment of cardiac arrhythmias. Russkiy Med- itsinskiy Zhurnal. 2012;(4):77. (In Russ.) [Соколов С.Ф. Аллапинин и современные подходы к лечению нарушений ритма сердца. Русский Медицинский Журнал. 2012;(4):77].; Elesin D.A., Romanov A.B., Turov A.N., et al. Radiofrequency ablation of paraxysmal and prolonged persistent atrial fibrillation: one-year follow-up with the use of continuous subcutaneous monitoring. Vestnik Aritmologii. 2011;63:5-11. (In Russ.) [Елесин Д.А., Романов А.Б., Туров А.Н. и др. Ра- диочастотная аблация пароксизмальной и длительно персистирующей форм фибрилляции пред- сердий: 1-летний период наблюдения с помощью непрерывного подкожного мониторирования. Вестник Аритмологии. 2011;63:5-11].; Goldenberg G.R., Burd D., Lodzinski P., et al. Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success - a meta-analysis. J Interv Card Electrophysiol. 2016;21:98-109.; Turco P, De Simone A., La Rocca V., et al. Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation. Pacing Clin Electrophysiol. 2007;30:S112-5.; Wu G., Jiang H., Huang C., et al. Effects of early postoperative antiarrhythmic drugs on atrial fibril- lation recurrence in the circumferential ablation of pulmonary vein. Chin J Canliol. 2008;36:7.; Darcner S., Chen X., Hansen J., et al. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind,radiomized, placebo-controlled study (AMIO- CAT trial). Eur Heart J. 2014;35:3356-64.; Kaitani K., Inoue K., Kobori A., et al. EAST-AF trial investigators. Efficacy of antiarrhythmic drugs short- term use after catheter ablation for atrial fibrillation (EAST-EF) trial. Eur Heart J. 2016;37(7);610-8.; https://www.rpcardio.com/jour/article/view/1408

الاتاحة: https://www.rpcardio.com/jour/article/view/1408
https://doi.org/10.20996/1819-6446-2017-13-1-18-24

المؤلفون: K. Davtyan V., O. Tkacheva N., A. Kalemberg A., S. Koretsky N., К. Давтян В., О. Ткачева Н., А. Калемберг А., С. Корецкий Н.

المصدر: Rational Pharmacotherapy in Cardiology; Vol 10, No 3 (2014); 307-311 ; Рациональная Фармакотерапия в Кардиологии; Vol 10, No 3 (2014); 307-311 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2014-10-3

مصطلحات موضوعية: atrial fibrillation, thromboembolic complications, left atrial appendage occluding system, фибрилляция предсердий, тромбоэмболические осложнения, окклюзирующие устройства в ушко левого предсердия

وصف الملف: application/pdf

Relation: https://www.rpcardio.com/jour/article/view/255/266; Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: Framingham Study. Stroke 1991;22:983-8.; Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillations in Olmsted country, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114(2):119-25.; Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. NEJM 2011;365:883-91.; Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. NEJM 2011;365:981-92.; Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. NEJM 2009;361:1139-51.; Levi MM, Eerenberg E, Löwenberg E, Kamphuise PW. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management. Neth J Med 2010;68(2):68-76.; Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61(2):755-9.; Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta medica Scandinavica 1969;185:373-9.; Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-9.; Camm JA, Colombo A, Corbucci G, Padeletti L. Left atrial appendage closure: a new technique for clinical practice. Heart Rhythm 2014;11(3):514-21.; Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011;123(4):417-24.; Hughes S. PREVAIL Yanked From ACC Program; Watchman Device Meets Safety End Point. Availale at: http://www.medscape.com/viewarticle/780535. Accessed by 20.06.2014.; Park JW. Amplatzer Cardiac Plug Post-Market Registry Interim Results. Frankfurt: CSI; 2011; Walsh K. Left atrial appendage closure with the Amplatzer Cardiac Plug: results of the European Prospective Observational Study. Paper presented at: EuroPCR 2012: Congress of the European Association of Percutaneous Cardiovascular Interventions. May 15-18, 2012; Paris, France.; Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012;79:794-800.; Santoro G. Amplatzer Cardiac Plug: Italian Registry. Paper presented at: XIV International Symposium on Progress in Clinical Pacing 2010. November 30-December 3, 2010; Rome, Italy.; Guérios EE, Schmid M, Gloekler S, et al. Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. Arq Bras Cardiol 2012;98:528-36.; López-Minguez JR, Eldoayen-Gragera J, Gonzalez-Fernandez R, et al. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer Cardiac Plug. Rev Esp Cardiol 2013;66:90-7.; Ureña M, Rodes-Cabau J, Freixa X, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol 2013;62:96-102.; Kefer J, Vermeersch P, Budts W, et al. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. Acta Cardiol 2013; 68(6):551-8.; Reddy VY, Möbius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013;61(25):2551-6.; Tzikas A, Karagounis L, Bouktsi M, Drevelegas Aet al. Left atrial appendage occlusion with the Amplatzer Amulet for stroke prevention in atrial fibrillation: the first case in Greece. Hellenic J Cardiol 2013;54(5):408-12. Поступила: 22.05.2014; https://www.rpcardio.com/jour/article/view/255

الاتاحة: https://www.rpcardio.com/jour/article/view/255
https://doi.org/10.20996/1819-6446-2014-10-3-307-311

المؤلفون: E. Belikov A., K. Davtyan V., O. Tkacheva N., Е. Беликов А., К. Давтян В., О. Ткачева Н.

المصدر: Rational Pharmacotherapy in Cardiology; Vol 10, No 4 (2014); 432-437 ; Рациональная Фармакотерапия в Кардиологии; Vol 10, No 4 (2014); 432-437 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2014-10-4

مصطلحات موضوعية: anticoagulants, atrial fibrillation, thromboembolic complications, антикоагулянты, фибрилляция предсердий, тромбоэмболические осложнения

وصف الملف: application/pdf

Relation: https://www.rpcardio.com/jour/article/view/191/199; RSSA guidelines for the VNOA electrophysiological studies, catheter ablation and implantable use of antiarrhythmic devices. Available at: http://www.vnoa.ru/literature/Recomend2013.pdf. Accessed by 20.08.2014. Russian (Клинические рекомендации ВНОА по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. Доступно на: http://www.vnoa.ru/literature/Recomend2013.pdf. Проверено 20.08.2014).; Calkins H, Brugada J, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation ofAtrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. J Interv Card Electrophysiol 2012;33(2):171-257; Cappato R, Calkins Н, Chen S et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ arrhythm electrophysiol 2010;3:32-8.; Siklódy CH, Deneke Т, Hocini M et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol 2011;58(7):681-8.; Camm AJ, Lip G, De Caterina R et al. Atrial fibrillation (management of) 2010 and focused update (2012), ESC clinical practice guidelines. Eur Heart J 2012;33:2719-47.; Diagnosis and treatment of atrial fibrillation. 2012 RSC/RSSA/RACVS guideline. Available at: http://scardio.ru/content/Guidelines/FP_rkj_13.pdf. Accessed by 06.08.2014. Russian (Диагностика и лечение фибрилляции предсердий. Рекомендации ВНОК, ВНОА, АССХ (2012). Доступно на: http://scardio.ru/content/Guidelines/FP_rkj_13.pdf. Проверено 06.08.2014).; Pisters RI, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138(5):1093-100.; Tapanainen JM, Braunschweig F, Schwieler J et.al. Сontinuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation. Scand Cardiovasc J 2013;47(2):109-13.; Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation 2014;129(25):2638-44.; Heidbuchel H, Verhamme P, Alings M, et.al. EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J 2013;34(27):2094-106.; Lakkireddy D, Reddy YM, Di Biase L, et.al. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol 2012;59(13):1168-74.; Winkle RA, Mead H, Engel G, et al. Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Ablation for Atrial Fibrillation. J Am Coll Cardiol 2012;60(12):1118-19.; Lakkireddy D, Reddy YM, Di Biase L et.al. Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial fibrillation results From a Multicenter Prospective Registry. J Am Coll Cardiol 2014;63(10):982-8.; Ren JF, Marchlinski F, Callans D, et al. Left atrial thrombus associated With ablation for atrial fibrillation: identification with intracardiac Echocardiography. J Am Coll Cardiol 2004;43(10):1861-7.; Shurrab M, Morillo С.A.Schulman S, et al. Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis. Canadian Journal Of Cardiology 2013;29(10):1203-10.; Eitel С, Koch J, Sommer P, et al. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation. EP Europace 2013;15(11):1587-93.; Ichiki H, Oketani N, Ishida S, et al. The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran. Pacing and Clinical Electrophysiology 2013;36(11):1328-35.; Registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. Available at: https://clinicaltrials.gov/ct2/show/NCT01729871?term=venture&rank=2. Accessed by 20.08.2014.; https://www.rpcardio.com/jour/article/view/191

الاتاحة: https://www.rpcardio.com/jour/article/view/191
https://doi.org/10.20996/1819-6446-2014-10-4-432-437